• 1:中华医学会心血管病学分会结构性心脏病学组
• 2:中国医师协会心血管内科医师分会结构性心脏病专业委员会

摘要(Abstract)：

<正>时至今日,经导管主动脉瓣置换术(transcatheter aorticvalvereplacement,TAVR)经过十余年的发展,其安全性和有效性已经过多个大型、多中心、前瞻性、随机对照研究以及临床注册研究证实[1-2],并逐渐扩大适应证向中低危患者过渡[3-5]。我国自2010年开始进行该领域实践,目前已经积累了1000余例

关键词(KeyWords)： 经导管主动脉瓣置换术;适应证;康复

Abstract:

Keywords:

基金项目(Foundation):

作者(Author):

参考文献(References)：

• [1]Cribier A,Eltchaninoff H,Bash A,et al.Percutaneous transcatheter implantation of an aortic valve prosthesis for calcifi c aortic stenosis:fi rst human case description.Circulation,2002,106(24):3006-3008.
• [2]Leon MB,Smith CR,Mack M,et al.Transcatheter aortic valve implantation for aortic stenosis in patients who cannot undergo surgery.N Engl J Med,2010,363(17):1597-1607.
• [3]Smith CR,Leon MB,Mack MJ,et al.Transcatheter versus surgical aortic valve replacement in high-risk patients.N Engl JMed,2011,364(23):2187-2198.
• [4]Leon MB,Smith CR,Mack MJ,et al.Transcatheter or surgical aortic-valve replacement in intermediate-risk patients.N Engl JMed,2016,374(17):1609-1620.
• [5]Thorani VH,Kodali S,Makkar RR,et al.Transcatheter aortic valve replacement versus surgical valve replacement in intermediaterisk patients:a propensity score analysis.Lancet,2016,387(10034):2218-2225.
• [6]Holmes Jr DR,Rich JB,Zoghbi WA,et al.The heart team of cardiovascular care.J Am Coll Cardiol,2013,61(9):903-907.
• [7]Shroyer AL,Coombs LP,Peterson ED,et al.The society of thoracic surgeons:30-day operative mortality and morbidity risk models.Ann Thorac Surg,2003,75(6):1856-1864.
• [8]Nashef SA,Roques F,Michel P,et al.European system f or cardiac operative risk evaluation(EuroSCORE).Eur JCardiothorac Surg,1999,16(1):9-13.
• [9]Arnold SV,Reynolds MR,Lei Y,et al.Predictors of poor outcomes after transcatheter aortic valve replacement:results from the PARTNER(Placement of Aortic Transcatheter Valve)trial.Circulation,2014,129(25):2682-2690.
• [10]中国医师协会心血管内科医师分会结构性心脏病专业委员.经导管主动脉瓣置换术中国专家共识.中国介入心脏病学杂志,2015,23(12):661-667.
• [11]Yoon SH,Bleiziff er S,De BO,et al.Procedural and clinical outcomes in transcatheter aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis.JACC,2017,69(21):2579-2589.
• [12]Song G,Jilaihawi H,Wang M,et al.Severe symptomatic bicuspid and tricuspid aortic stenosis in China:characteristics and outcomes of transcatheter aortic valve replacement with the venus-avalve.Structural Heart,2017,2(1):60-68.
• [13]Luo X,Wang X,Li X,et al.Transapical transcatheter aortic valve implantation using the J-valve TM system:a one-year follow-up study.J Thorac Cardiovasc Surg,2017,154(1):46-55.
• [14]Yoon SH,Schmidt T,Bleiziff er S,et al.Transcatheter aortic valve replacement in pure native aortic valve regurgitation.JACC,2017,70(22):2752.
• [15]Nishimura RA,Otto C M,Bonow RO,et al.2017 AHA/ACCfocused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease:a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines.J Am Coll Cardiol,2017,70(2):252-289.
• [16]Haude M.Management of valvular heart disease:ESC/EACTSguidelines 2017.Herz,2017,42(8):715-720.
• [17]Cerillo AG,Mariani M,Berti S,et al.Sizing the aortic annulus.Ann Cardiothorac Surg,2012,1(1):245-256.
• [18]Liu X,He Y,Zhu Q,et al.Supra-annular structure assessment for self-expanding transcatheter heart valve size selection in patients with bicuspid aortic valve.Catheter Cardiovasc Interv,2018,91(5):986-994.
• [19]Kurra V,Kapadia SR,Tuzcu EM,et al.Pre-procedural imaging of aortic root orientation and dimensions:comparison between X-ray angiographic planar imaging and 3-dimensional multidetector row computed tomography.JACC Cardiovasc Interv,2010,3(1):105-113.
• [20]Nakatani S.Subclinical leafl et thrombosis afte transcatheter aortic valve implantation.Heart,2017,103(24):1942-1946.
• [21]Doherty JU,Kort S,Mehran R,et al.ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2017 appropriate use criteria for multimodality imaging in valvular heart disease.J Nucl Cardiol,2017,24(6):2043-2063.
• [22]Bavaria JE,Tommaso CL,Brindis RG,et al.2018 AATS/ACC/SCAI/STS expert consensus systems of care document:operator and institutional recommendations and requirements for transcatheter aortic valve replacement:ajoint report of the American Association for Thoracic Surgery,the American College of Cardiology,the Society for Cardiovascular Angiography and Interventions,and the Society of Thoracic Surgeons.J Am Coll Cardiol,2018.[Epub ahead of print].
• [23]Dvir D,Jhaveri R,Pichard AD.The minimalist approach for transcatheter aortic valve replacement in high-risk patients.JACCCardiovasc Interv,2012,5(5):468-469.
• [24]Toggweiler S,Gurvitch R,Leipsic J,et al.Percutaneous aortic valve replacement.Vascular outcomes with a fully percutaneous procedure.J Am Coll Cardiol,2012,59:113-118.
• [25]Schymik G,Würth A,Bramlage P,et al.Long-term results of transapical versus transfemoral TAVI in a real world population of 1000 patients with severe symptomatic aortic stenosis.Circ Cardiovasc Interv,2015,8:e000761.
• [26]Grube E,Naber C,Abizaid A,et al.Feasibility of transcatheter aortic valve implantation without balloon pre-dilation:a pilot study.JACC Cardiovasc Interv,2011,4(7):751-757.
• [27]Maisano F,Taramasso M,Nietlispach F.Prognostic infl uence of paravalvular leak following TAVI:is aortic regurgitation an active incremental risk factor or just a mere indicator?Eur Heart J,2015,36(7):413.
• [28]Genereux P,Head SJ,Hahn R,et al.Paravalvular leak after transcatheter aortic valve replacement:the new Achilles’heel?Acomprehensive review of the literature.J Am Coll Cardiol,2013,61(11):1125-1136.
• [29]Takagi K,Latib A,Al-Lamee R,et al.Predictors of moderate-tosevere paravalvular aortic regurgitation immediately after CoreValve implantation and the impact of postdilatation.Catheter Cardiovasc Interv,2011,78(3):432-443.
• [30]Latib A,Naganuma T,Abdelwahab M,et al.Treatment and clinical outcomes of transcatheter heart valve thrombosis.Circ Cardiovasc Interv,2015,8(4).pii:e001779.
• [31]Généreux P,Head SJ,Van Mieghem NM,et al.Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions:a weighted meta-analysis of 3,519 patients from 16 studies.J Am Coll Cardiol,2012,59(25):2317-2326.
• [32]Kappetein AP,Head SJ,Généreux P,et al.Updated standardized endpoint defi nitions for transcatheter aortic valve implantation:the Valve Academic Research Consortium-2 consensus document.Eur JCardiothorac Surg,2012,33(19):2403-2418.
• [33]Adams DH1,Popma JJ,Reardon MJ,et al.Transcatheter aorticvalve replacement with a self-expanding prosthesis.N Engl J Med,2014,370(19):1790-1798.
• [34]Rodés-Cabau J,Kahlert P,Neumann FJ,et al.Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement:the PROTAVI-C pilot study.JACC Cardiovasc Interv,2014,7(10):1146-1155.
• [35]Nazif TM,Dizon JM,Hahn RT,et al.Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement:the PARTNER(Placement of AoRtic TraNscathetER Valves)trial and registry.JACC Cardiovasc Interv,2015,8(1):60-69.
• [36]Tarantini G,Mojoli M,Purita P,et al.Unravelling the(arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve.Euro Intervention,2014,11(3):343-350.
• [37]De BO,Arnous S,Sandholt B,et al.Safety and effi cacy of using the viabahn endoprosthesis for percutaneous treatment of vascular access complications after transfemoral aortic valve implantation.JAm Coll Cardiol,2015,115(8):1123-1129.
• [38]Ribeiro HB,Webb JG,Makkar RR,et al.Predictive factors,management,and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation:insights from a large multicenter registry.J Am Coll Cardiol,2013,62(17):1552-1562.
• [39]Moat NE,Ludman P,de Belder MA,et al.Long-term outcomes after transcatheter aortic valve implantation in highrisk patients with severe aortic stenosis:the U.K.TAVI(United Kingdom Transcatheter Aortic Valve Implantation)Registry.J Am Coll Cardiol,2011,58(20):2130-2138.